pyridoxal phosphate has been researched along with Focal Nodular Hyperplasia in 7 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Focal Nodular Hyperplasia: Solitary or multiple benign hepatic vascular tumors, usually occurring in women of 20-50 years of age. The nodule, poorly encapsulated, consists of a central stellate fibrous scar and normal liver elements such as HEPATOCYTES, small BILE DUCTS, and KUPFFER CELLS among the intervening fibrous septa. The pale colored central scar represents large blood vessels with hyperplastic fibromuscular layer and narrowing lumen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The lesions in hepatocellular carcinomas patients showed a non-homogeneous enhancement pattern." | 1.33 | Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images. ( Adigüzel, Y; Haykir, R; Karabacakoğlu, A; Karaköse, S; Kayaçetin, E, 2006) |
| "For patients in whom the diagnosis of focal nodular hyperplasia cannot be established on unenhanced or gadolinium-enhanced MR imaging, homogeneous uptake of liver-specific contrast agent with better delineation of central scar may help to make a confident diagnosis of focal nodular hyperplasia." | 1.31 | Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents. ( Ba-Ssalamah, A; Helbich, T; Kurtaran, A; Laengle, F; Linnau, KF; Mann, FA; Reimer, P; Ryan, M; Schibany, N; Schima, W; Schmook, MT; Wrba, F, 2002) |
| "Hepatocyte-containing liver neoplasms such as hepatomas or focal nodular hyperplasia (FNH), take up MnDPDP and demonstrate varying degrees of enhancement." | 1.31 | MnDPDP enhanced magnetic resonance imaging of focal liver lesions. ( Burkill, GJ; Healy, JC; King, LJ; Murray-Lyons, I; Scurr, ED; Vlavianos, P, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ba-Ssalamah, A | 1 |
| Schima, W | 1 |
| Schmook, MT | 1 |
| Linnau, KF | 1 |
| Schibany, N | 1 |
| Helbich, T | 1 |
| Reimer, P | 1 |
| Laengle, F | 1 |
| Wrba, F | 1 |
| Kurtaran, A | 1 |
| Ryan, M | 1 |
| Mann, FA | 1 |
| King, LJ | 1 |
| Burkill, GJ | 1 |
| Scurr, ED | 1 |
| Vlavianos, P | 1 |
| Murray-Lyons, I | 1 |
| Healy, JC | 1 |
| Savellano, DH | 1 |
| Köstler, H | 1 |
| Baus, S | 1 |
| Mössinger, M | 1 |
| Gratz, KF | 1 |
| Weimann, A | 1 |
| Galanski, M | 1 |
| Karabacakoğlu, A | 1 |
| Adigüzel, Y | 1 |
| Karaköse, S | 1 |
| Kayaçetin, E | 1 |
| Haykir, R | 1 |
| Martin, DR | 1 |
| Semelka, RC | 1 |
| Chung, JJ | 1 |
| Balci, NC | 1 |
| Wilber, K | 1 |
| Grimm, J | 1 |
| Müller-Hülsbeck, S | 1 |
| Blume, J | 1 |
| Biederer, J | 1 |
| Heller, M | 1 |
| De Gaspari, A | 1 |
| De Cobelli, F | 1 |
| Del Maschio, A | 1 |
1 review available for pyridoxal phosphate and Focal Nodular Hyperplasia
| Article | Year |
|---|---|
[Magnetic resonance imaging of the liver: what kind of contrast agents?].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DT | 2001 |
1 trial available for pyridoxal phosphate and Focal Nodular Hyperplasia
| Article | Year |
|---|---|
[Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
Topics: Adenoma; Adult; Aged; Biopsy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cysts; Diagnosis, Diffe | 2001 |
5 other studies available for pyridoxal phosphate and Focal Nodular Hyperplasia
| Article | Year |
|---|---|
Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents.
Topics: Adult; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Focal Nodular Hyperplasia | 2002 |
MnDPDP enhanced magnetic resonance imaging of focal liver lesions.
Topics: Adenoma, Liver Cell; Adult; Aged; Cholangiocarcinoma; Contrast Media; Edetic Acid; Female; Focal Nod | 2002 |
Assessment of sequential enhancement patterns of focal nodular hyperplasia and hepatocellular carcinoma on mangafodipir trisodium enhanced MR imaging.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Focal Nodular Hyperplas | 2004 |
Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarc | 2006 |
Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Focal Nodular Hyperplasia | 2000 |